SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the crypto community discusses potential catalysts for a price surge, including comparisons to Bitcoin's movements and speculation about an upcoming alt season. Community members are debating Litecoin's utility and future growth potential, with some expressing frustration over its historical performance, while others point to its privacy features and upcoming ETFs. The conversations reflect a mix of hope for a breakout and concern about potential pump-and-dump schemes.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors discuss the potential impact of recent acquisitions and upcoming contracts, particularly the Lunar Terrain Vehicle (LTV) project. Community members are weighing the implications of increased revenue and backlog against concerns of possible stock dilution. Bullish sentiment revolves around LUNR's strategic positioning in the growing space economy and its potential to secure lucrative government contracts.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as the community discusses its potential in the AI sector and recent partnerships, while some traders are closely watching for bullish signals and breakouts. User growth seems to be a key factor driving recent price action, with some speculating about the future value. Bullish sentiment seems to be increasing with some community members expressing excitement about alt season.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. is trending amid discussions around potential ACA subsidy extensions and government shutdown negotiations, with community members weighing the potential impacts on the healthcare sector. Trump's stance on sending federal health insurance money directly to individuals is also fueling debate, with some viewing it as potentially beneficial for insurers like CNC. Traders are actively discussing potential entry and exit points, as well as the stock's technical strength in a volatile market.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk ($NVO) is trending as investors digest news of Pfizer ($PFE) winning the bid for Metsera, a deal NVO pursued, and its potential impact on NVO's growth strategy. The community is discussing whether NVO strategically drove up the price for Pfizer and what acquisition target NVO might pursue next to bolster its pipeline in the competitive obesity and diabetes market. Some traders are noting oversold conditions and anticipating a potential rebound, while others express concern about the company's near-term outlook.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending as community members discuss its potential for decentralized applications and its unique technology, with some drawing comparisons to early-stage tech giants. Talk centers on its recent price surge and whether it can sustain its momentum, while others point to its long-term potential and growing ecosystem. Bullish sentiment seems to be fueled by the belief that ICP is undervalued and poised for significant growth.

Sibanye Stillwater Ltd. is a multinational mining and metals processing group with a diverse portfolio of operations, projects and investments across five continents. It is one of the global recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. The firm mainly engages in the acquisition and exploration of platinum group materials including palladium, rhodium and producing of gold. It also produces and refines iridium, ruthenium, nickel, chrome, copper and cobalt. The company has diversified its asset portfolio into battery metals mining and processing. Sibanye Stillwater was founded on February 1, 2013 and is headquartered in Weltevreden Park, South Africa.

Sibanye Stillwater Limited - ADR

Sibanye Gold Limited

$SBSW is trending as investors discuss recent Q3 profit increases driven by PGM prices, with community members highlighting major institutional buys and positive EBITDA. Some are speculating on potential for platinum and palladium to increase in value, while others express concerns about the stock's volatility and dependence on metal prices.

The Signata project aims to deliver a full suite of blockchain-powered identity and access control solutions, including hardware token integration and a marketplace of smart contracts for integration with 3rd party service providers.

Signata

Signata (SATA), connected to $ASST, is trending due to recent news of an investment by Vivek Ramaswamy into its preferred shares. The community is discussing the structure of $SATA, which offers a dividend yield backed by $ASST's Bitcoin holdings and a Section 351 Exchange Program. Some are also watching for potential Robinhood availability.

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) is trending due to a post-earnings sell-off despite beating EPS estimates, as revenue misses and lowered guidance are raising concerns. The community is discussing the company's weaker-than-expected sales, particularly in international markets, and debating whether the sell-off is an overreaction. Community members are also discussing various analyst ratings, potential entry points, and call option strategies, while also comparing ZBH's fundamentals to competitors.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot (DOT) is trending amid community discussions about potential ETF approvals and its long-term prospects, with some traders anticipating a price surge. Despite some negativity, its integrations and tokenomics are still sparking interest. Some users highlight its staking rewards while others worry about the token's price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stifel upgraded Biogen  from Hold to Buy in a Thursday note, raising its price target to $202 from $144, citing an improving risk/reward profile for the stock due to multiple clinical catalysts and a potential &quot;narrative shift&quot; in Alzheimer&#39;s disease. 
&quot;This is not a recommendation based on the core business,&quot; wrote analyst Paul Matteis, noting that Biogen&#39;s third-quarter results were mixed, and the firm expects the fourth quarter to be &quot;barely acceptable.&quot; Instead, Stifel sees upside potential over the next 12 months driven by developments in Biogen&#39;s Alzheimer’s pipeline and beyond. 
According to Stifel, Biogen’s shares could benefit from &quot;the potential success of LLY’s TB3 trial, which could fundamentally change how patients, doctors, and investors think about abeta antibodies,&quot; as well as the &quot;likely approval for the initiation of lecanemab SQ,&quot; which could alleviate current treatment bottlenecks.  
$LLY   $IONS   $BIIB

StockTwits Web

Lilly(Eli) & Co

Ionis Pharmaceuticals Inc

Biogen Inc

Stifel upgraded Biogen  from Hold to Buy in a Thursday note, raising its price target to $202 from $144, citing an improving risk/reward profile for the stock due to multiple clinical catalysts and a potential "narrative shift" in Alzheimer's disease. 
"This is not a recommendation based on the core business," wrote analyst Paul Matteis, noting that Biogen's third-quarter results were mixed, and the firm expects the fourth quarter to be "barely acceptable." Instead, Stifel sees upside potential over the next 12 months driven by developments in Biogen's Alzheimer’s pipeline and beyond. 
According to Stifel, Biogen’s shares could benefit from "the potential success of LLY’s TB3 trial, which could fundamentally change how patients, doctors, and investors think about abeta antibodies," as well as the "likely approval for the initiation of lecanemab SQ," which could alleviate current treatment bottlenecks.  
